Accession Number: | 0001209191-21-013594 |
Date: | 2021-02-19 |
Issuer: | IGM BIOSCIENCES, INC. (IGMS) |
Original Submission Date: |
TOPSOE CHRISTINA TENG
C/O IGM BIOSCIENCES, INC.
325 E. MIDDLEFIELD ROAD
MOUNTAIN VIEW, CA 94043
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 91.5 | 2021-02-19 | deemed execution date | A | 6,423 (a) | 2031-02-19 | common stock 6,423 | $91.50 | 6,423 | direct |
ID | footnote |
---|---|
f1 | 1/12 of the shares subject to the option shall vest each month following the issuer's 2021 annual meeting of stockholders on the same day of the month, subject to reporting person remaining a service provider through each such date. notwithstanding the foregoing, the shares subject to the option will be fully vested no later than the date of the issuer's 2022 annual meeting of stockholders. |